Search results
Second Circuit dismisses suit against drugmaker that paid competitors to delay generic release
Courthouse News Service· 18 hours agoThe manufacturer of a lucrative blood pressure drug did not violate antitrust laws by paying...
Israel’s Once-Dominant Drugmaker Is Revived by Innovation
The Wall Street Journal via Yahoo Finance· 5 hours agoConsistent success in that arena could lead investors to value it as an innovative company rather...
8 Expensive Costco Items That Are Definitely Not Worth the Cost
GOBankingRates via Yahoo Finance· 4 hours agoIf you've ever been inside a Costco, you know it's a great place to go if you want to buy in bulk...
What Forced the Cannes Market to Offer Smarter Movies? Strikes Get Some of the Credit
Indiewire via Yahoo News· 4 hours agoIt will demand that a film is the best version it can be of itself, and with that it needs a little...
Yes, allergy season is particularly bad. Here's why it's about to get worse — and what you can do to...
Pittsburgh Tribune-Review· 7 days agoAllergy sufferers need not look past their vehicle’s hood to see why this season is so bad — if...
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
Reuters· 5 days agoIndian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on Thursday,...
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 5 days agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
Rachel Cruze: 2 Items I Always Buy the Cheapest Version Of — And 1 I Spend More On
GOBankingRates via Yahoo Finance· 3 days agoThere are always some items worth paying more for, but other times, the cheaper version will...
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 6 days agoGlaxo’s patent for Zantac’s active ingredient, ranitidine, expired in 1997. That same year,...
Teva, Medincell's schizophrenia drug succeeds in late-stage study
Reuters via AOL· 6 days agoU.S.-listed shares of Teva were up 3.3% at $14.41 in premarket trading. The companies hope that the...